aod9604 efficacy fat loss clinical trials AOD 9604 Peptide for Loss: Does It Work? AOD‑9604 Peptide for Fat Loss:

AOD-9604 + CJC-1295 + Ipamorelin (12mg Blend Vial) Dosage Protocol Lipolytic hGH fragment (AOD-9604) + GHRH analog (CJC-1295) + GH secretagogue (Ipamorelin) in one 12 mg blend research-only, not FDA-approved

We provide itemized medical invoices and DHA receipts should you wish to pursue private reimbursement

This dual action can accelerate fat loss and body recomposition

Cannabinoids exert their action on the human body by binding to the receptors that make up the endocannabinoid system, namely CB1 and CB2 receptors

In animal studies, AOD-9604 reduced body weight gain by over 50% in obese mice during a 19-day treatment period, and significantly increased fat oxidation all without affecting insulin sensitivity or glucose regulation.[1,3] A randomized controlled trial in humans found that participants taking 1 mg of AOD-9604 daily lost an average of 2.8 kg (~6 lbs) over 23 weeks, compared to 0.8 kg (~1.7 lbs) in the placebo group

Potential Benefits of AOD-9604 AOD-9604 1